| | NERVE AGENT VX - PROPOSED TEMPORARY ACUTE EXPOSURE |
| | 0,27 | | MB | GUIDELINE LEVELS (AEGLs) |
| | 71 | | stron |
| | 4649 | | ID | UNITED STATES ENVIRONMENTAL PROTECTION AGENCY |
| | 2001 | | rok |
| | TABLE OF CONTENTS |
| | PREFACE . i |
| | LIST OF TABLES . iv |
| | EXECUTIVE SUMMARY . v |
| | 1. INTRODUCTION . 1 |
| | 2. HUMAN TOXICITY DATA . 4 |
| | 2.1. Acute Lethality 4 |
| | 2.2. Nonlethal Toxicity . 4 |
| | 2.2.1. Acute Exposure Studies 5 |
| | 2.2.2. Epidemiologic Studies 9 |
| | 2.3. Neurotoxicity 9 |
| | 2.4. Developmental/Reproductive Toxicity . 9 |
| | 2.5. Genotoxicity . 9 |
| | 2.6. Carcinogenicity . 10 |
| | 2.7. Summary . 10 |
| | 3. ANIMAL TOXICITY DATA 11 |
| | 3.1. Acute Lethality 11 |
| | 3.2. Nonlethal Toxicity . 12 |
| | 3.2.1. Rats 12 |
| | 3.2.2. Mice . 13 |
| | 3.2.3. Guinea Pigs 13 |
| | 3.2.4. Rabbits . 13 |
| | 3.3. Neurotoxicity 14 |
| | 3.4. Developmental/Reproductive Toxicity . 15 |
| | 3.5. Genotoxicity . 16 |
| | 3.6. Carcinogenicity . 17 |
| | 3.7. Summary . 17 |
| | 4. SPECIAL CONSIDERATIONS 17 |
| | 4.1. Metabolism and Disposition 17 |
| | 4.2. Mechanism of Toxicity 18 |
| | 4.3. Relative Potency . 18 |
| | 4.4. Structure-Activity Relationships 22 |
| | 4.5. Other Relevant Information . 23 |
| | 4.5.1. Breathing Rates and Toxicity 23 |
| | 4.5.2. Delayed Neuropathy . 23 |
| | 4.5.3. Intra- and Inter-Species Variability in Esterase Activity and Response to Nerve Agents 24 |
| | 4.5.4. Unique Physicochemical Properties . 26 |
| | 4.5.5. Concurrent Exposure Issues . 26 |
| | 4.5.6. Critical Effect Endpoint 28 |
| | 4.5.7. Casualty Management and Care 28 |
| | 5. DATA ANALYSIS AND PROPOSED AEGL-1 . 29 |
| | 5.1. Summary of Human Data Relevant to AEGL-1 . 29 |
| | 5.2. Summary of Animal Data Relevant to AEGL-1 . 30 |
| | 5.3. Derivation of AEGL-1 30 |
| | 6. DATA ANALYSIS AND PROPOSED AEGL-2 . 31 |
| | 6.1. Summary of Human Data Relevant to AEGL-2 . 31 |
| | 6.2. Summary of Animal Data Relevant to AEGL-2 . 31 |
| | 6.3. Derivation of AEGL-2 31 |
| | 7. DATA ANALYSIS AND PROPOSED AEGL-3 . 32 |
| | 7.1. Summary of Human Data Relevant to AEGL-3 . 32 |
| | 7.2. Summary of Animal Data Relevant to AEGL-3 . 33 |
| | 7.3. Derivation of AEGL-3 33 |
| | 8. SUMMARY OF PROPOSED AEGLS 34 |
| | 8.1. AEGL Values and Toxicity Endpoints . 34 |
| | 8.2. Comparison with Other Standards and Criteria 35 |
| | 8.3. Data Adequacy and Research Needs 36 |
| | 9. REFERENCES 38 |
| | APPENDIX A: Derivation of AEGL Values . A-1 |
| | APPENDIX B: Summary Tables .. B-1 |